DCB offers a full CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats) based gene editing service, to produce a genetically modified cell using any mammalian cell line and targeting any gene.
CRISPR/Cas9 systems is a newly developed yet the most popular method for genome editing. Our scientists are experts at performing gene editing with CRISPR, from designing specific gRNA constructs to transfection and single clone generation of a wide range of cells.
Why DC Biosciences?
Expert guidance through project design and completion
Many years of experience with a variety of cell lines
Cost-effective and competitive pricing
Continual interaction at all stages of the process